Pivot X - Search Results

1

Impact of STAT3 phosphorylation on the clinical effectiveness of anti-EGFR-based therapy in patients with metastatic colorectal cancer.

Dobi E, Monnien F, Kim S, Ivanaj A, N'Guyen T, Demarchi M, Adotevi O, Thierry-Vuillemin A, Jary M, Kantelip B, Pivot X, Godet Y, Degano SV, Borg C. Dobi E, et al. Among authors: pivot x. Clin Colorectal Cancer. 2013 Mar;12(1):28-36. doi: 10.1016/j.clcc.2012.09.002. Epub 2012 Oct 17. Clin Colorectal Cancer. 2013. PMID: 23083634

2

[Chemotherapy for patients with local-regional recurrent or metastatic carcinoma of the head and neck].

Dufresne A, Gainet M, Stein U, Guardiola E, Pivot X. Dufresne A, et al. Among authors: pivot x. Bull Cancer. 2003 Jan;90(1):39-45. Bull Cancer. 2003. PMID: 12609803 Free article. Review. French.

3

Prognostic impact of the epidermal growth factor receptor levels for patients with larynx and hypopharynx cancer.

Pivot X, Magné N, Guardiola E, Poissonnet G, Dassonville O, Francoual M, Formento JL, Bensadoun RJ, Demard F, Schneider M, Milano G. Pivot X, et al. Oral Oncol. 2005 Mar;41(3):320-7. doi: 10.1016/j.oraloncology.2004.09.011. Oral Oncol. 2005. PMID: 15743695

4

Economic impact of simplified de Gramont regimen in first-line therapy in metastatic colorectal cancer.

Limat S, Bracco-Nolin CH, Legat-Fagnoni C, Chaigneau L, Stein U, Huchet B, Pivot X, Woronoff-Lemsi MC. Limat S, et al. Among authors: pivot x. Eur J Health Econ. 2006 Jun;7(2):107-13. doi: 10.1007/s10198-006-0338-1. Eur J Health Econ. 2006. PMID: 16474968

5

Natural killer cells prevent CD28-mediated Foxp3 transcription in CD4+CD25- T lymphocytes.

Brillard E, Pallandre JR, Chalmers D, Ryffel B, Radlovic A, Seilles E, Rohrlich PS, Pivot X, Tiberghien P, Saas P, Borg C. Brillard E, et al. Among authors: pivot x. Exp Hematol. 2007 Mar;35(3):416-25. doi: 10.1016/j.exphem.2006.12.004. Exp Hematol. 2007. PMID: 17309822 Free article.

6

Impact of chemotherapy beyond the first line in patients with metastatic breast cancer.

Dufresne A, Pivot X, Tournigand C, Facchini T, Altweegg T, Chaigneau L, De Gramont A. Dufresne A, et al. Among authors: pivot x. Breast Cancer Res Treat. 2008 Jan;107(2):275-9. doi: 10.1007/s10549-007-9550-7. Epub 2007 Mar 23. Breast Cancer Res Treat. 2008. PMID: 17380382

7

[Pemetrexed development in oncology].

Chaigneau L, Villanueva C, Thierry-Vuillemin A, Legat-Fagnoni C, N'Guyen T, Maurina T, Lorgis V, Pivot X. Chaigneau L, et al. Among authors: pivot x. Bull Cancer. 2007;94 Spec No Actualites:S142-8. Bull Cancer. 2007. PMID: 17845985 Review. French.

8

Role of STAT3 in CD4+CD25+FOXP3+ regulatory lymphocyte generation: implications in graft-versus-host disease and antitumor immunity.

Pallandre JR, Brillard E, Créhange G, Radlovic A, Remy-Martin JP, Saas P, Rohrlich PS, Pivot X, Ling X, Tiberghien P, Borg C. Pallandre JR, et al. Among authors: pivot x. J Immunol. 2007 Dec 1;179(11):7593-604. doi: 10.4049/jimmunol.179.11.7593. J Immunol. 2007. PMID: 18025205

9

Anticancer therapy in patients with porphyrias: evidence today.

Thiery-Vuillemin A, Chaigneau L, Meaux-Ruault N, Villanueva C, N'guyen T, Maurina T, Stein U, Lorgis V, Demarchi M, Pivot X. Thiery-Vuillemin A, et al. Among authors: pivot x. Expert Opin Drug Saf. 2008 Mar;7(2):159-65. doi: 10.1517/14740338.7.2.159. Expert Opin Drug Saf. 2008. PMID: 18324878

10

Ixabepilone, a novel epothilone analog in the treatment of breast cancer.

Pivot X, Villanueva C, Chaigneau L, Nguyen T, Demarchi M, Maurina T, Stein U, Borg C. Pivot X, et al. Expert Opin Investig Drugs. 2008 Apr;17(4):593-9. doi: 10.1517/13543784.17.4.593. Expert Opin Investig Drugs. 2008. PMID: 18363523 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

356 results

Search Page